A federal appeals courtroom upheld dismissal of litigation filed towards Lloyd’s of London in a case of a person whose loss of life was attributed to ingesting a dietary complement that had been banned by the Federal Drug Administration. The FDA had already banned DMAA, an amphetamine by-product that has been marketed in sports activities… Continue reading Lloyd’s wins ruling in death from nutritional supplement